JUPITER NEUROSCIENCES, INC. (JUNS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch JUNS
See up to 3 months of JUNS. The 7-day demo opens the 1M and 3M ranges and puts JUNS on your watchlist.
Start 7-day demoLatest JUNS insider trades
About JUPITER NEUROSCIENCES, INC. (JUNS)
The SEC lists JUPITER NEUROSCIENCES, INC. under CIK 0001679628, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector. A registration statement was filed on 26 November 2025. No offering has priced.
JUNS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 472,222 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
JUNS insider transactions (Form 4)
5422 Form 4 filings on record, the earliest from Jul 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andrew Jon Cutler - Director | Grant or award | Stock Option (right to buy) | 472,222 | $0.00 | - | |
| Julie B. Kampf - Director | Option exercise | Common Stock | 82,875 | - footnote F1 | - | |
| Julie B. Kampf - Director | Option exercise | Restricted Stock Units | 82,875 | $0.00 | - | |
| ||||||
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Common Stock | 164,553 | - footnote F1 | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Common Stock | 96,608 | - footnote F1 | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Restricted Stock Units | 164,554 | $0.00 | - | |
| Alexander Gustaf Erik Rosen - Officer | Option exercise | Restricted Stock Award | 96,608 | $0.00 | - | |
| ||||||
 Marshall A. Hayward - Officer | Option exercise | Common Stock | 389,793 | - footnote F1 | - | |
| Marshall A. Hayward - Officer | Option exercise | Common Stock | 399,402 | - footnote F1 | - | |
| Marshall A. Hayward - Officer | Option exercise | Common Stock | 225,000 | - footnote F3 | - | |
| Marshall A. Hayward - Officer | Option exercise | Restricted Stock Units | 389,793 | $0.00 | - | |
| Marshall A. Hayward - Officer | Option exercise | Restricted Stock Award | 399,402 | $0.00 | - | |
| Marshall A. Hayward - Officer | Option exercise | Stock Option (right to buy) | 225,000 | $0.00 | - | |
| ||||||
| Nicholas H. Hemmerly - Director | Option exercise | Common Stock | 95,550 | - footnote F1 | - | |
| Nicholas H. Hemmerly - Director | Option exercise | Restricted Stock Units | 95,550 | $0.00 | - | |
| ||||||
 Holger Weis - Director | Option exercise | Common Stock | 85,800 | - footnote F1 | - | |
| Holger Weis - Director | Option exercise | Restricted Stock Units | 85,800 | $0.00 | - | |
| ||||||
| Tomas Jan Philipson - Director | Grant or award | Stock Option (right to buy) | 536,428 | $0.00 | - | |
 Allison W. Brady - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Saleem Elmasri - Officer | Grant or award | Stock Option | 525,565 | $0.00 | - | |
| Christer Rosen - Officer | Grant or award | Stock Option | 747,783 | $0.00 | - | |
| Nicholas H. Hemmerly - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Julie B. Kampf - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Alison D. Silva - Officer | Grant or award | Stock Option | 1,027,304 | $0.00 | - | |
| Marshall A. Hayward - Officer | Grant or award | Stock Option | 259,231 | $0.00 | - | |
| Holger Weis - Director | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Alexander Gustaf Erik Rosen - Officer | Grant or award | Stock Option | 341,843 | $0.00 | - | |
| Saleem Elmasri - Officer | Option exercise | Common Stock | 66,293 | $0.00 | - | |
| Saleem Elmasri - Officer | Grant or award | Stock Option (right to buy) | 102,128 | - | - | |
| Alison D. Silva - Officer | Grant or award | Stock Option (right to buy) | 255,320 | - | - | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.03 | $257 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.03 | $257 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.03 | $259 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 500 | $1.01 | $505 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 3,100 | $1.02 | $3K | |
| Alison D. Silva - Officer | Option exercise | Common Stock | 110,227 | $0.00 | - | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.00 | $250 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 100 | $1.04 | $103 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.04 | $261 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.05 | $263 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 100 | $1.02 | $102 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.02 | $255 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.03 | $258 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 250 | $1.04 | $259 | |
| Alison D. Silva - Officer | Open-market purchase | Common Stock | 100 | $1.05 | $105 | |
| Christer Rosen - Officer | Option exercise | Common Stock | 497,396 | $0.00 | - | |
| Christer Rosen - Officer | Option exercise | Common Stock | 476,070 | $0.00 | - | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 166 | $1.06 | $176 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,000 | $0.98 | $980 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 2,000 | $1.01 | $2K | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,450 | $1.02 | $1K | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 700 | $1.03 | $721 | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,500 | $1.04 | $2K | |
| Christer Rosen - Officer | Open-market purchase | Common Stock | 1,000 | $1.05 | $1K | |
Item 5.03, 9.01
Item 3.01, 8.01, 9.01
Item 1.01, 5.02, 8.01, 9.01
Item 8.01, 9.01
JUNS insider trading FAQ
What is the latest insider trade for JUNS?
JUPITER NEUROSCIENCES, INC. (JUNS) had 1 insider filing in the last 90 days, with the most recent on 2026-08-05. The full record for JUNS runs to 22 Form 4 filings, the earliest from 2025-07-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying JUNS stock?
No insider purchases of JUNS were filed in the last 90 days. 21 purchases are on record for this company.
How many insiders are selling JUNS stock?
No insider sales of JUNS were filed in the last 90 days.
Where can I see JUNS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects JUNS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew Jon Cutler view on EDGAR
- - Julie B. Kampf view on EDGAR
- - Alexander Gustaf Erik Rosen view on EDGAR
- - Marshall A. Hayward view on EDGAR
- - Nicholas H. Hemmerly view on EDGAR
- - Holger Weis view on EDGAR
- - Tomas Jan Philipson view on EDGAR
- - Allison W. Brady view on EDGAR
- - Saleem Elmasri view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where JUNS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow JUNS with a 7-day demo
- JUNS on your watchlist
- Every JUNS Form 4 filing on record
- Up to 3 months of JUNS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
